Neuraxis NRXS
NYSE NRXS
$7.12 +0.03 (+0.42%)
At close: Oct 2, 2026 · 4:00 PM EDT

Neuraxis (NRXS) Gains from Sales and Divestitures (2025)

Updated

Neuraxis (NRXS) reported Gains from Sales and Divestitures of -$7,878 for FY2025.

Analysis

Neuraxis (NRXS) Gains from Sales and Divestitures (2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 242.18 Bn 221.33 Bn 4.88 Bn
2 Abbott Laboratories 168.71 Bn 139.79 Bn 7.27 Bn
3 Danaher 150.46 Bn 134.27 Bn 3.61 Bn
4 Intuitive Surgical 138.71 Bn 118.26 Bn 1.96 Bn
5 Medtronic 110.54 Bn 76.41 Bn 6.34 Bn
6 Stryker 105.66 Bn 91.78 Bn 4.50 Bn
7 Boston Scientific 61.74 Bn 56.75 Bn 3.85 Bn
8 Edwards Lifesciences 49.09 Bn 33.21 Bn 1.35 Bn
9 Becton Dickinson 48.16 Bn 45.31 Bn 2.32 Bn
10 Neuraxis 88.77 Mn 64.03 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 -7,710.00
Jun 30, 2025 365.00
Mar 31, 2025 -533.00
API Access

Neuraxis Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=NRXS&period=max&api_key=YOUR_API_KEY